Thought Leadership

Latest Report


EvaluatePharma World Preview 2018, Outlook to 2024

The latest annual World Preview 2018, Outlook to 2024 shows that orphan drugs are forecast to remain one of the fastest growth areas of the global pharmaceutical market. The rare disease space is predicted to capture 20% of the total $1.2trn market in 2024. Supporting this growth are the launches of novel therapies, including gene and…

Report library


EvaluatePharma Orphan Drug Report 2018

Our 2018 Orphan Drug Report shows continuing unmet medical need is set to fuel the growth of the worldwide orphan drug market with sales predicted to grow at over 11% a…


EP Vantage 2018 Preview

An uptick in M&A activity and investor cash is expected to re-invigorate Pharma and Biotech in 2018. The upward momentum seen in the pharma and biotech sectors…